AVENUE THERAPEUTICS, INC. Research and Development in Process
AVENUE THERAPEUTICS, INC. (ATXI) reported Research and Development in Process of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2019-03-12
- AVENUE THERAPEUTICS, INC. research and development in process for the quarter ending 2017-03-31 was $49.00K.
- AVENUE THERAPEUTICS, INC. research and development in process for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- AVENUE THERAPEUTICS, INC. research and development in process for fiscal 2017 was $1.10M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 11 month | Research and Development in Process 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 | ||
| 2017-12-31 | $1.10M 10-K · filed 2019-03-12 | ||
| 2017-03-31 | $49.00K 10-Q · filed 2017-05-12 | ||
| 2016-12-31 | $49.00K 10-Q · filed 2018-11-14 | ||
| 2015-12-31 | $3.04M 10-K · filed 2018-03-01 |